TY - JOUR
T1 - Exploring the Role of miR-132 in Rat Bladders and Human Urothelial Cells during Wound Healing
AU - Chamorro, Clara I
AU - Fossum, Magdalena
PY - 2024/10/14
Y1 - 2024/10/14
N2 - Urinary bladder wound healing shares many features with skin healing, involving several molecular players, including microRNAs (miRs). This study investigated the role of miR-132 in urothelial cells. We analyzed miR-132 expression in rat bladder using in situ hybridization and conducted gain and loss of miR-132 function assays in primary human urothelial cells (HUCs). These assays included cell proliferation and migration studies. To explore the regulation of miR-132 expression, cells were treated with wound-healing-related factors such as interleukin 6 (IL-6), interleukin 10 (IL-10), and transforming growth factor beta-1 (TGF-β1). Predictive bioinformatics and a literature review identified potential miR-132 targets, which were validated through real-time polymerase chain reaction (RT-PCR) and Western blot analysis. miR-132 was found to promote cellular proliferation and migration during the early stages of urothelial wound repair. Its expression was modulated by key cytokines such as IL-6, IL-10, and TGF-β1. miR-132 played a crucial role in urothelial wound healing by enhancing cell proliferation and migration, regulated by cytokines, suggesting its action within a complex regulatory network. These findings highlight the therapeutic potential of targeting miR-132 in bladder injury repair, offering new insights into bladder repair mechanisms.
AB - Urinary bladder wound healing shares many features with skin healing, involving several molecular players, including microRNAs (miRs). This study investigated the role of miR-132 in urothelial cells. We analyzed miR-132 expression in rat bladder using in situ hybridization and conducted gain and loss of miR-132 function assays in primary human urothelial cells (HUCs). These assays included cell proliferation and migration studies. To explore the regulation of miR-132 expression, cells were treated with wound-healing-related factors such as interleukin 6 (IL-6), interleukin 10 (IL-10), and transforming growth factor beta-1 (TGF-β1). Predictive bioinformatics and a literature review identified potential miR-132 targets, which were validated through real-time polymerase chain reaction (RT-PCR) and Western blot analysis. miR-132 was found to promote cellular proliferation and migration during the early stages of urothelial wound repair. Its expression was modulated by key cytokines such as IL-6, IL-10, and TGF-β1. miR-132 played a crucial role in urothelial wound healing by enhancing cell proliferation and migration, regulated by cytokines, suggesting its action within a complex regulatory network. These findings highlight the therapeutic potential of targeting miR-132 in bladder injury repair, offering new insights into bladder repair mechanisms.
KW - MicroRNAs/genetics
KW - Humans
KW - Wound Healing/genetics
KW - Urinary Bladder/metabolism
KW - Animals
KW - Rats
KW - Urothelium/metabolism
KW - Cell Proliferation
KW - Cell Movement/genetics
KW - Transforming Growth Factor beta1/metabolism
KW - Cells, Cultured
KW - Interleukin-6/metabolism
KW - Interleukin-10/metabolism
KW - Gene Expression Regulation
KW - urinary bladder
KW - urothelium
KW - bladder wound healing
KW - microRNA
KW - human
UR - http://www.scopus.com/inward/record.url?scp=85207432730&partnerID=8YFLogxK
U2 - 10.3390/ijms252011039
DO - 10.3390/ijms252011039
M3 - Journal article
C2 - 39456820
SN - 1661-6596
VL - 25
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 20
M1 - 11039
ER -